Delivery Order SPE2DB22D3016-SPE2DB25FBCX0
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $24,939.36 to AmerisourceBergen Drug Corp for 30-unit supplies of Orgovyx 120 mg tablets, with an ultimate completion date of August 26, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which carries a potential value of $999,999,999.00 through December 2026. The place of performance is located...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $1,385.52 firm fixed price delivery order for 30 tablets of Orgovyx 120 mg on August 4, 2025, with an ultimate completion date of August 25, 2025. This non-set-aside competitive award is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The pharmaceutical product will be performed at...
- The Defense Logistics Agency awarded a delivery order valued at $4,156.56 to AmerisourceBergen Drug Corp for supply of Orgovyx 120 mg tablets (30-count units) on August 13, 2025, with completion targeted for September 4, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's facility in Conshohocken, Pennsylvania. Orgovyx is a gonadotropin-releasing hormone receptor agonist used in the treatment of advanced...
- The Defense Logistics Agency awarded a delivery order valued at $16,626.24 to AmerisourceBergen Drug Corp for the supply of Orgovyx 120 mg tablets (30-count units) on July 21, 2025, with an ultimate completion date of August 11, 2025. This is a firm fixed price delivery order with no set-aside designation, indicating competitive award. The product will be delivered to AmerisourceBergen's location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp Corporate Office Division. The $7,979.34 firm fixed-price contract is for the supply of 120 mg Orgovyx tablets. Orgovyx is a prescription medication used to treat advanced prostate cancer. The contract has an ultimate completion date of August 28, 2024. Amerisourcebergen is a major pharmaceutical distributor that has been awarded numerous federal contracts to provide...
- The Defense Logistics Agency awarded a delivery order valued at $2,771.04 to AmerisourceBergen Drug Corp for 30 tablets of Orgovyx 120 mg, a prescription medication used in the treatment of prostate cancer. The contract is a firm fixed price delivery order with an ultimate completion date of August 8, 2025, and was competitively awarded without set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform fulfillment from its corporate office...
- The Defense Logistics Agency awarded a $4,156.56 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Orgovyx 120 mg tablets (30-count units) on August 4, 2025, with an ultimate completion date of August 25, 2025. This delivery order represents a competitive award with no set-aside designation and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Orgovyx is a pharmaceutical product used in hormone therapy, consistent with...
- The Defense Logistics Agency awarded a $1,385.52 delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Orgovyx 120 mg tablets (30-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 20, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's broader Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $5,542.08 to AmerisourceBergen Drug Corp for the supply of Orgovyx 120 mg tablets (30-count unit of use packaging) on July 21, 2025, with an ultimate completion date of August 11, 2025. This competitively awarded, firm fixed-price contract with no set-aside designation represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and...
- The Defense Logistics Agency awarded a $4,156.56 delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Orgovyx 120 mg tablets in quantities of 30 units. This is a firm fixed price delivery order with an ultimate completion date of August 11, 2025, and represents a non-set-aside, competitively awarded contract. The pharmaceutical product will be delivered to the Conshohocken, Pennsylvania location, which serves as AmerisourceBergen's corporate headquarters and...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB25FBCX0Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,771.04 to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Orgovyx 120 mg tablets (30-unit packages). This is a firm fixed-price, non-set-aside contract with a completion date of August 14, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. Orgovyx is a prescription medication used in the treatment of prostate cancer, representing the type of specialized pharmaceutical product that supports military and federal healthcare systems. This delivery order falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion comprehensive pharmaceutical supply agreement running through December 2026. As a major pharmaceutical distributor and established federal vendor, AmerisourceBergen serves as a critical supplier of brand-name and generic medications, vaccines, and medical devices across multiple therapeutic domains to support Defense Health Agency and other government healthcare systems. The company's demonstrated capability to fulfill federal medical procurement requirements through competitive awards positions it as a key provider within the federal pharmaceutical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.8k | 7/24/25 |